MSTR has made a rapid turn from overbought to neutral on its 1D technical outlook (RSI = 48.944, MACD = 14.210, ADX = 17.986) as it reached today a -40% decline from its ATH but eventually hit the 1D MA50 and rebounded. This is the first contact with the 1D MA50 since September 19th. Even though it seems like a strong technical buy opportunity, Microstrategy has had its best buy entries in the last 2 years, under the 1D MA50. As this chart shows there have been 8 such buy signals, so even though the current rebound is tempting, we ideally want to see the price under the 1D MA50 and $300 before issuing a buy signal. Once this is filled, we can target the December 5th High minimum (TP = 400).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
Telegram: t.me/investingscope
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Telegram: t.me/investingscope
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% return monthly on our Account Management Plan.
Account RECOVERY services.
Free Channel: t.me/investingscopeofficial
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.